NYKD — Nykode Therapeutics ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Nykode Therapeutics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	228	206	162	115	60.3
Net Total Accounts Receivable
Net Total Receivables	26.2	4.33	1.07	0.908	1.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	256	212	166	117	61.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.16	9.53	10.5	7.74	5.68
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	266	221	208	153	100
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	31.4	39	20.6	9.1	6.19
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	71.5	64.5	36.9	17.3	8.42
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	194	157	171	136	91.5
Total Liabilities & Shareholders' Equity	266	221	208	153	100
Total Common Shares Outstanding